1. Home
  2. INAB vs GTEC Comparison

INAB vs GTEC Comparison

Compare INAB & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

N/A

Current Price

$1.39

Market Cap

13.7M

Sector

Health Care

ML Signal

N/A

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

N/A

Current Price

$0.64

Market Cap

13.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
INAB
GTEC
Founded
2016
2006
Country
United States
United States
Employees
N/A
340
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
13.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INAB
GTEC
Price
$1.39
$0.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
65.1K
142.4K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.62
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.01
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$0.47
52 Week High
$2.73
$2.26

Technical Indicators

Market Signals
Indicator
INAB
GTEC
Relative Strength Index (RSI) 40.09 51.15
Support Level $1.35 $0.64
Resistance Level $1.85 $0.73
Average True Range (ATR) 0.11 0.06
MACD -0.03 0.00
Stochastic Oscillator 17.56 51.74

Price Performance

Historical Comparison
INAB
GTEC

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

Share on Social Networks: